JP2011505811A5 - - Google Patents

Download PDF

Info

Publication number
JP2011505811A5
JP2011505811A5 JP2010537314A JP2010537314A JP2011505811A5 JP 2011505811 A5 JP2011505811 A5 JP 2011505811A5 JP 2010537314 A JP2010537314 A JP 2010537314A JP 2010537314 A JP2010537314 A JP 2010537314A JP 2011505811 A5 JP2011505811 A5 JP 2011505811A5
Authority
JP
Japan
Prior art keywords
rubella
antigen
cys
fusion protein
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010537314A
Other languages
English (en)
Japanese (ja)
Other versions
JP5461423B2 (ja
JP2011505811A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/010532 external-priority patent/WO2009074318A2/en
Publication of JP2011505811A publication Critical patent/JP2011505811A/ja
Publication of JP2011505811A5 publication Critical patent/JP2011505811A5/ja
Application granted granted Critical
Publication of JP5461423B2 publication Critical patent/JP5461423B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010537314A 2007-12-13 2008-12-11 新規風疹ｅ１エンベロープタンパク質変異体および抗風疹抗体の検出におけるその使用 Active JP5461423B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07024190 2007-12-13
EP07024190.6 2007-12-13
PCT/EP2008/010532 WO2009074318A2 (en) 2007-12-13 2008-12-11 Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies

Publications (3)

Publication Number Publication Date
JP2011505811A JP2011505811A (ja) 2011-03-03
JP2011505811A5 true JP2011505811A5 (enExample) 2011-06-30
JP5461423B2 JP5461423B2 (ja) 2014-04-02

Family

ID=40671057

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010537314A Active JP5461423B2 (ja) 2007-12-13 2008-12-11 新規風疹ｅ１エンベロープタンパク質変異体および抗風疹抗体の検出におけるその使用

Country Status (7)

Country Link
US (1) US8551696B2 (enExample)
EP (1) EP2222694B1 (enExample)
JP (1) JP5461423B2 (enExample)
CN (1) CN101939330B (enExample)
CA (1) CA2705716C (enExample)
ES (1) ES2450998T3 (enExample)
WO (1) WO2009074318A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2706115A1 (en) 2012-09-06 2014-03-12 Roche Diagnostics GmbH Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays
EA201500503A1 (ru) 2012-11-08 2015-10-30 Ф.Хоффманн-Ля Рош Аг Анти-her3/her4 антигенсвязывающие белки, связывающиеся с бета-шпилькой her3 и бета-шпилькой her4
MX2016014862A (es) 2014-05-14 2017-02-27 Hoffmann La Roche Her3 / her2 anticuerpos biespecificos que se unen a la horquilla beta de her3 y al dominio ii de her2.
CN108136000B (zh) * 2015-09-30 2022-11-08 勃林格殷格翰动物保健有限公司 经改良的模块化抗原转运分子及其在动物中的用途
BR112018012055A2 (pt) * 2015-12-15 2018-12-04 Hoffmann La Roche substrato de transglutaminase (tg) recombinante, método in vitro para marcar uma proteína de interesse, composição farmacêutica ou de diagnóstico e kit de diagnóstico
WO2020010009A1 (en) * 2018-07-02 2020-01-09 Siemens Healthcare Diagnostics Inc. Direct immunoassay measurement of autoantibodies
DE102019004812B4 (de) 2019-07-10 2021-03-18 Institut Virion-Serion GmbH Würzburg Rubella Virus Spike Konstrukt
CN115197941A (zh) * 2021-04-08 2022-10-18 中国科学院分子细胞科学卓越创新中心 具有分子伴侣功能的rna及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU736670B2 (en) 1996-09-26 2001-08-02 Medical Research Council Chaperone fragments
ATE289354T1 (de) * 1999-04-15 2005-03-15 Crucell Holland Bv Verwendung von adenovirus e1 protein sequenzen kodierenden, zur herstellung von rekombinanten proteinen in menschlichen zellen.
EP1103610A1 (en) * 1999-11-26 2001-05-30 Introgene B.V. Production of vaccines from immortalised mammalian cell lines
PL215170B1 (pl) 2001-06-22 2013-10-31 Hoffmann La Roche Sposób wytwarzania rozpuszczalnego kompleksu zawierajacego amyloidogenne bialko docelowe oraz bialko opiekuncze z klasy izomeraz peptydyloprolilowych
EP1780282B1 (en) * 2005-10-26 2010-12-08 Roche Diagnostics GmbH Recombinant expression of Rubella E1 envelope protein variants as chaperone fusion-proteins, and their use in the detection of anti-Rubella antibodies
CA2562738C (en) * 2005-10-26 2011-07-12 F. Hoffmann-La Roche Ag Soluble rubella e1 envelope antigens

Similar Documents

Publication Publication Date Title
JP2011505811A5 (enExample)
JP2009284902A5 (enExample)
JPWO2022040482A5 (enExample)
CN106279410B (zh) 一种二型登革热病毒ns1蛋白多价纳米抗体及制备方法
JP2005120106A5 (enExample)
CN116355092B (zh) 抗人血清白蛋白的纳米抗体及其应用
CN104215761B (zh) 检测血清中抗gp73抗体的试剂盒
JP2024109778A (ja) 免疫グロブリンＦｃドメインに対する結合親和性を持たない新規三重らせんポリペプチド及び同ポリペプチドの使用
CN113087792A (zh) 一种犬瘟热病毒纳米抗体及其应用
CN103304645A (zh) 重组链球菌溶血素o蛋白、核苷酸序列、制备方法及应用
CN105063065A (zh) 密码子优化型1型鸭甲肝病毒vp1基因及其重组蛋白的应用
CN106928358A (zh) 一种CD105纳米抗体Nb168
CN105510580A (zh) 一种检测发热伴血小板减少综合征病毒核衣壳蛋白特异性抗体的多肽-酶联免疫吸附试剂盒
CN106928365A (zh) 一种FAP纳米抗体Nb36
JP2017512200A5 (enExample)
CN106928360B (zh) 一种CD105纳米抗体Nb68
CN106928355B (zh) 一种CD105纳米抗体Nb184
CN105606816B (zh) 一种检测发热伴血小板减少综合征病毒包膜糖蛋白特异性抗体的多肽‑酶联免疫吸附试剂盒
CN110627869B (zh) 与禽法氏囊病毒vp2蛋白特异性结合的多肽序列及其应用
JP2009542243A5 (enExample)
CN102276700B (zh) 一种猪戊型肝炎病毒抗原表位及它的应用
CN106928359B (zh) 一种CD105纳米抗体Nb59
Won et al. B3 (Fab)-streptavidin tetramer has higher binding avidity than B3 (scFv)-streptavidin tetramer
JP7038367B2 (ja) 抗ＳＡＲＳ－ＣｏＶ－２抗体
CN119060158B (zh) 一种重组抑制素b抗原及其制备方法与应用